The trademark HEPATOCORD was filed by ACCORD HEALTHCARE LIMITED, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on November 2, 2023, and received one opposition filed on December 3, 2023 by VECOS NUCOCEUTICAL, S.L. on Likelihood of confusion. the opponent was represented by CONSIANGAR, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 3, 2023
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).